Navigation Links
Leukopenia in Medical News

Genetic Variation Associated With Survival Advantage in African Americans With HIV

... Duffy antigen receptor for chemokine (DARC) and leukopenia have slower HIV-to-AIDS progression rates than ... (WBC) counts than persons of European ancestry. leukopenia is one of several blood conditions observed ... is relatively unknown. "Even though leukopenia is tied to both African ancestry and faster ...

Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer

... of patients with NSCLC were anemia (8 vs 7); leukopenia (5 vs 28); neutropenia (5 vs ... of patients with MPM were neutropenia (24 vs 4); leukopenia (16 vs 1); anemia (6 vs 0); thrombocytopenia (5 ... alone, respectively, were neutropenia (58 vs 16); leukopenia (55 vs 20); anemia (33 vs 14); thrombocytopenia ...

ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)

... of patients with NSCLC were anemia (8 vs 7); leukopenia (5 vs 28); neutropenia (5 vs ... of patients with MPM were neutropenia (24 vs 4); leukopenia (16 vs 1); anemia (6 vs 0); thrombocytopenia (5 ... alone, respectively, were neutropenia (58 vs 16); leukopenia (55 vs 20); anemia (33 vs 14); thrombocytopenia ...

New therapy with stem cells to treat Crohn's disease

... Initial Chemotherapy (Cyclophosphamide + G-CSF). In this initial phase, leukopenia or reduction of the number of leukocytes (immune-system cells) in the ... until ready for transplant. Second Chemotherapy. In this phase, total leukopenia is induced; that is, the immune system is left devoid of leukocytes, ready ...

Novel therapeutic approaches may improve patient outcomes in several platelet disorders

... by 15 to 25 percent. Secondary objectives included safety, duration of leukopenia and thrombocytopenia, and the number of red blood cell transfusions. ... no life-threatening or fatal bleeding was reported. The duration of leukopenia and the need for red blood cell transfusions were the same in both arms. ...

Gene Mutation Increases Drug Toxicity, Rejection Risk in Pediatric Kidney Transplants

... transferase. Adverse side effects most commonly linked to MMF have included gastrointestinal complications (such as diarrhea) or leukopenia - a drop in white blood cell count that can put patients at higher risk for infections. In some instances, patients have to be taken off the drug or ...

Novel treatments show improvements in survival and response rates for leukemia and lymphoma

... in the FCR arm as compared with 62.3 percent in the FC arm. While FCR was found to cause more neutropenia (33.6 percent versus 20.9 percent) and leukopenia (24 percent versus 12.1 percent), it did not increase the incidence of severe infections (18.8 percent versus 14.8 percent) as compared with FC. ...

Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma

... in the FCR arm as compared with 62.3 percent in the FC arm. While FCR was found to cause more neutropenia (33.6 percent versus 20.9 percent) and leukopenia (24 percent versus 12.1 percent), it did not increase the incidence of severe infections (18.8 percent versus 14.8 percent) as compared with FC. ...

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

... nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...

Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting

... commonly occurring adverse reactions by SC route were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...
Leukopenia in Medical Technology

Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders

... by 15 to 25 percent. Secondary objectives included safety, duration of leukopenia and thrombocytopenia, and the number of red blood cell transfusions. ... no life-threatening or fatal bleeding was reported. The duration of leukopenia and the need for red blood cell transfusions were the same in both arms. ...

Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes

... cisplatin for the treatment of patients with MPM were neutropenia (24%); leukopenia (16%); anemia (6%); thrombocytopenia (5%); infection without neutropenia ... with ALIMTA for the treatment of patients with NSCLC were anemia (8%); leukopenia (5%); neutropenia (5%); thrombocytopenia (2%); infection without ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

... (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), anemia (43% vs 55%), constipation (37% vs 16%), neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% vs 26%), lymphopenia (24% vs 17%), anorexia (23% vs 10%), asthenia (21% vs ...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

... insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood cell counts, including leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid ...

New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma

... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common Grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), ...

New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer

... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common Grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), ...

Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer

... phosphatase (68%), elevated serum creatinine (57%), lymphopenia (53%), hypophosphatemia (49%), thrombocytopenia (40%), elevated AST (38%), and leukopenia (32%). Most common grades 3/4 adverse events included asthenia (11%), dyspnea (9%), hemoglobin decreased (20%), lymphocytes decreased (16%), glucose ...

GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)

... CINV is 24 hours to 120 hours following treatment.(8) The most commonly reported all-cause adverse events in the treatment arms were neutropenia, leukopenia and anemia, which occurred at a higher rate in the casopitant arms. The incidence of serious neutropenia adverse events was two percent in the active ...

Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer

... or life-threatening) adverse events were neutropenia (a decrease in the number of granular white blood cells, 54%); febrile neutropenia, 5.5%, leukopenia (low white blood cell count, 14%), and weakness/fatigue (10%; no Grade 4 events). Grade 3 peripheral neuropathy (a functional disturbance or damage ...
Leukopenia in Medical Dictionary

Leukopenia

... leukopenia - An abnormally low white blood cell count. ... Slightly higher counts are seen in children. leukopenia : Lower than the normal amount of white blood ... For: search help Printer-Friendly Format ... leukopenia : An abnormally low number of white blood cells ...

Thrombocytopenia

... medications known to cause thrombocytopenia or leukopenia as a side effect. Note: Clinical trials ... by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and ... ( anemia ), low white blood cell count ( leukopenia ) with a tendency to infection , and low ...

Hernia

... that stimulates thyroid hormone production. pan immunity ; pan leukopenia ; pan leukopenia virus of cats; panlobular emphysema ; panmixis; panmyelophthisis; ...

Leukocytes

... blood cells, the blood cells responsible for fighting infection . leukopenia ... Granular leukocytes -- they are better known as granulocyte s ... infections , inflammation of mammary glands , intestinal antiseptic, leukopenia (reduction in blood leukocytes ), ... identified to be correlated ...

Neuritis

... panic ulated; panic um; panidiomorphic; panidrosis; pan immunity ; pan leukopenia ; pan leukopenia virus of cats; panlobular emphysema ; panmixis; panmyelophthisis; ...

Acute myelogenous leukemia

... in patients being treated for acute myelogenous leukemia . is characterized by low red blood cells ( anemia ), low white blood cell count ( leukopenia ) with a tendency to infection , and low platelet count ( thrombocytopenia ) with bleeding problems. MDS may progress and transform into acute ...

Anorexia

... Zantryl (ION Labor atories). Graft vs Host Disease - The clinical entity characterized by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and eventual death brought about by the GRAFT VS HOST REACTION. Starving for Control: The Truth ...

Diarrhea

... for pain relief during an attack. Graft vs Host Disease - The clinical entity characterized by anorexia , diarrhea , loss of hair , leukopenia , thrombocytopenia , growth retardation , and eventual death brought about by the GRAFT VS HOST REACTION. Gastrointestinal (e.g., ...

Diplopia

... extensive, but use of this drug is limited in the cancer population because of concern that it causes bone marrow suppression, in particular leukopenia . Other common adverse effects include nystagmus , dizziness , diplopia , ... ...

Folliculitis

... elevations or bumps on the skin ) that may grow together to form plaques. eosinophil ic leukocyte; eosinophil ic leukocytosis; eosinophil ic leukopenia ; eosinophil ic lung disease ; eosinophil ic meningitis ; eosinophil ic meningo encephalitis ; eosinophil ic pneumonia ; eosinophil ic ...

More>>

Leukopenia in Biological News

Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants

... transferase. Adverse side effects most commonly linked to MMF have included gastrointestinal complications (such as diarrhea) or leukopenia a drop in white blood cell count that can put patients at higher risk for infections. In some instances, patients have to be taken off the drug or ...

Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer

... or life- threatening) adverse events were neutropenia (a decrease in the number of granular white blood cells, 54%); febrile neutropenia, 5.5%, leukopenia (low white blood cell count, 14%), and weakness/fatigue (10%; no Grade 4 events). Grade 3 peripheral neuropathy (a functional disturbance or damage ...
Leukopenia in Biological Technology

FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer

... included: neutropenia (Grade 3/4: 54%) and leukopenia (Grade 3/4: 49%). (Phase III, Combination Trial: ... included: neutropenia (Grade 3/4: 68%) and leukopenia (Grade 3/4: 57%). Comparative treatment-related ... capecitabine alone included: neutropenia 11% and leukopenia 6%. IMPORTANT SAFETY INFORMATION TOXICITY IN ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... (73%), diarrhea (72%), and nausea (55%). The most common grade 3/4 adverse events (greater than or equal to 10%) included: diarrhea (22%), leukopenia (17%), asthenia/malaise (16%), and acneform rash (14%) Important Safety Information for ALIMTA ALIMTA is approved by the FDA in combination with ...

EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes

... commonly occurring adverse reactions by SC route were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...

FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma

... insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood cell counts, including leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid ...

Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium

... one patient is too early to evaluate. There have been no episodes of Grade 4 (i.e., life-threatening) side-effects. Four patients experienced Grade 3 leukopenia (i.e., reduction in white blood cell count), and 1 patient had Grade 3 thrombocytopenia (i.e., reduction in platelet count). "Our goal with this ...

Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes

... the most commonly occurring adverse reactions were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other ...
Other Contents
(Date:8/30/2014)... Acne is a common problem millions of American ... more than a daily nuisance, for some, it can have a ... can even lead to dramatic mood swings and depression. , ... clear up their skin. In some cases, that can make the ... and error, those on a quest for clearer skin can now ...
(Date:8/30/2014)... August 30, 2014 Continuing to meet ... is expanding with the addition of a new doctor ... who has provided leading-edge skin care in Grand Rapids ... , “As a doctor, my passion is making ... partnering with Forefront Dermatology, I’m better able to focus ...
(Date:8/30/2014)... medication commonly used to treat gout, before and ... potential complications from this type of surgery, but ... effects, according to a study published by ... online to coincide with its presentation at the ... after cardiac surgery include postpericardiotomy syndrome (the occurrence ...
(Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... consolidated litigation for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ... the company’s request to sever four cases selected ... to an Order issued on August 18, 2014, ... Southern District of West Virginia disagrees with Boston ...
(Date:8/30/2014)... August 30, 2014 One of the most ... is the gluten-free diet. Originally meant for sufferers of gluten ... catchall for people who are looking to get healthier by ... only is this kind of information erroneous, it also exposes ... because of a drastic change in their food consumption ...
Breaking Medicine News(10 mins):Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2
(Date:8/28/2014)... a handful of bacterial culprits that may drive inflammatory ... colitis, using patients, own intestinal immune responses as a ... the journal Cell . , Trillions of bacteria ... critical role in the development and progression of IBD. ... bacterial species affect a person,s susceptibility to IBD and ...
(Date:8/28/2014)... researcher and his collaborators have developed an online analytic ... of re-engineering cells for biomedical investigation. CellNet is a ... aid stem cell engineering. Details of CellNet and its ... back-to-back papers in the journal Cell . , ... for all types of cell-based investigations and can potentially ...
(Date:8/28/2014)... Aug. 28, 2014  Privacy Advocate and Senior Staff ... Lynch , joins the lineup of biometric and mobile ... Biometrics UnPlugged Executive Summit in Tampa, Florida ... Previously announced speakers include Steven Rahman, Director, Technology and Strategy ... at Experian. The theme of this year,s event is ...
Breaking Biology News(10 mins):Yale study identifies possible bacterial drivers of IBD 2New tool aids stem cell engineering for medical research 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
Other TagsOther Tags